Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01498991

Spinal Cord Injury Leg Rehabilitation (AMES)

Rehabilitation of the Lower Extremity With AMES Following Incomplete Spinal Cord Injury (SCI)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Paraplegia Quadriplegia Spinal Cord Injury Tetraplegia

Updated 9 times since 2017 Last updated: May 2, 2019 Started: Nov 30, 2011 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute of Neurological Disorders and Stroke (NINDS)

See all terminations from National Institute of Neurological Disorders and Stroke (NINDS)

Other Paraplegia trials with similar outcome

NCT06222398 · Dec 2025

Browse all Paraplegia trials

Listed as NCT01498991, this PHASE1/PHASE2 trial focuses on Paraplegia and Quadriplegia and remains terminated or withdrawn. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 9 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE1_PHASE2
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE1_PHASE2

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE1_PHASE2
Jun 2019 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2

Status: Completed → Terminated
Jun 2018 — Jun 2019 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)
Oregon Health and Science University
Shepherd Center, Atlanta GA

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States
• Portland, United States